Adenoid hypertrophy—​diagnosis and treatment: the new S2k guideline

Abstract

Hyperplasia of the pharyngeal tonsils is to be considered pathologic when nasopharyngeal symptoms of mechanical obstruction and/or chronic inflammation occur. Chronic Eustachian tube dysfunction can result in various middle ear diseases such as conductive hearing loss, cholesteatoma, and recurrent acute otitis media. During examination, attention should be paid to the presence of adenoid facies (long face syndrome), with a permanently open mouth and visible tip of the tongue. In the case of severe symptoms and/or failure of conservative treatment, adenoidectomy is usually performed on an outpatient basis. Conventional curettage remains the established standard treatment in Germany. Histologic evaluation is indicated for clinical evidence of mucopolysaccharidoses. Due to the risk of hemorrhage, the preoperative bleeding questionnaire, which is obligatory before every pediatric surgery, is referred to. Recurrence of adenoids is possible despite correct adenoidectomy. Before discharge home, otorhinolaryngologic inspection of the nasopharynx for secondary bleeding should be performed and anesthesiologic clearance obtained.

Efficacy of montelukast for adenoid hypertrophy in paediatrics: A systematic review and meta‐analysis

“…While the unusual growth of the adenoids refers to adenoid hypertrophy (A.H.) that can cause obstructive sleep apnea (OSA), ear problems, pulmonary hypertension, craniofacial anomalies and an inability to grow if it is not adequately handled. 3 Recently, research has demonstrated that x-rays for the lateral neck view and nasal endoscopy are the mainstay tests for diagnosing A.H. 4 In children, adenoidectomy is used to remove enlarged adenoids; however, there are still postoperative hazards such as haemorrhage and the possibility of recurrence of adenoid mass. 5 Medical treatment for adenoid hypertrophy has been suggested due to surgical costs, the risk of anaesthesia and other surgical-related complications.…”